21 CFR § 607.26 Establishment Registration and Product Listing for Manufacturers of Human Blood and Blood Products and Licensed Devices

§ 607.26 Amendments to establishment registration.

Current through Sep 8, 2026 · Read all of Part 607

Changes in individual ownership, corporate or partnership structure, location, or blood product handling activity must be submitted electronically through the Blood Establishment Registration and Product Listing system, or any future superseding electronic system, as an amendment to registration within 5 calendar days of such changes. Changes in the names of officers and directors of the corporations do not require such amendment but must be shown at time of annual registration.

[40 FR 52788, Nov. 12, 1975, as amended at 66 FR 59158, Nov. 27, 2001; 81 FR 60222, Aug. 31, 2016]

← § 607.25 Information required for establishment registration and blood product listing.§ 607.30 Updating blood product listing information. →